Pneumococcal carriage and serotype variation before and after introduction of pneumococcal conjugate vaccines in patients with acute otitis media in Switzerland

Vaccine

Volumn 35, Issue 15, 2017, Pages 1946-1953

  Allemann, Aurélie ^a   Frey, Pascal M ^a,b,c   Brugger, Silvio D ^a,b,d   Hilty, Markus ^a,c  

^a UNIVERSITY OF BERN   (Switzerland)

^b FORSYTH INSTITUTE   (United States)

^c UNIVERSITY OF BERN   (Switzerland)

^d HARVARD SCHOOL OF DENTAL MEDICINE   (United States)

Author keywords

Acute otitis media; Logistic regression; PCV13; PCV7; Pneumococcus

Indexed keywords

PNEUMOCOCCUS VACCINE; 13-VALENT PNEUMOCOCCAL VACCINE;

ACUTE OTITIS MEDIA; ADOLESCENT; ARTICLE; CHILD; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; INFANT; INFECTION PREVENTION; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEROTYPE; STREPTOCOCCUS PNEUMONIAE; SWITZERLAND; VACCINATION; ADULT; AGED; CLASSIFICATION; HETEROZYGOTE; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MIDDLE AGED; MIDDLE EAR; NASOPHARYNX; NEWBORN; OTITIS MEDIA; PNEUMOCOCCAL INFECTION; PREVALENCE; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BACTERIOLOGICAL TECHNIQUES; CARRIER STATE; CHILD; CHILD, PRESCHOOL; EAR, MIDDLE; FEMALE; HEPTAVALENT PNEUMOCOCCAL CONJUGATE VACCINE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; NASOPHARYNX; OTITIS MEDIA; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; PREVALENCE; RETROSPECTIVE STUDIES; SEROGROUP; STREPTOCOCCUS PNEUMONIAE; SWITZERLAND; YOUNG ADULT;

EID: 85014521937     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2017.02.010     Document Type: Article

References (37)

1. [1] Rovers, M.M., Schilder, A.G., Zielhuis, G.A., Rosenfeld, R.M., Otitis media. Lancet 7:363 (2004), 465–473.
2. [2] Rovers, M.M., The burden of otitis media. Vaccine 23:26 Suppl 7 (2008), G2–G4.
3. [3] Dagan, R., Leibovitz, E., Greenberg, D., Bakaletz, L., Givon-Lavi, N., Mixed pneumococcal-nontypeable Haemophilus influenzae otitis media is a distinct clinical entity with unique epidemiologic characteristics and pneumococcal serotype distribution. J Infect Dis 1:208 (2013), 1152–1160.
4. [4] Simell, B., Auranen, K., Kayhty, H., Goldblatt, D., Dagan, R., O'Brien, K.L., et al. The fundamental link between pneumococcal carriage and disease. Expert Rev Vaccines 11 (2012), 841–855.
5. [5] Ben-Shimol, S., Givon-Lavi, N., Leibovitz, E., Raiz, S., Greenberg, D., Dagan, R., Near-elimination of otitis media caused by 13-valent pneumococcal conjugate vaccine (PCV) serotypes in southern Israel shortly after sequential introduction of 7-valent/13-valent PCV. Clin Infect Dis 15:59 (2014), 1724–1732.
6. [6] Galanis, I., Lindstrand, A., Darenberg, J., Browall, S., Nannapaneni, P., Sjostrom, K., et al. Effects of PCV7 and PCV13 on invasive pneumococcal disease and carriage in Stockholm, Sweden. Eur Respir J 47 (2016), 1208–1218.
7. [7] Patrzalek, M., Kotowska, M., Gorynski, P., Albrecht, P., Indirect effects of a 7 year PCV7/PCV13 mass vaccination program in children on the incidence of pneumonia among adults: a comparative study based on two Polish cities. Curr Med Res Opin 32 (2016), 397–403.
8. [8] Shea, K.M., Weycker, D., Stevenson, A.E., Strutton, D.R., Pelton, S.I., Modeling the decline in pneumococcal acute otitis media following the introduction of pneumococcal conjugate vaccines in the US. Vaccine 19:29 (2011), 8042–8048.
9. [9] Eskola, J., Kilpi, T., Palmu, A., Jokinen, J., Haapakoski, J., Herva, E., et al. Efficacy of a pneumococcal conjugate vaccine against acute otitis media. N Engl J Med 8:344 (2001), 403–409.
10. [10] Mackenzie, G.A., Carapetis, J.R., Leach, A.J., Morris, P.S., Pneumococcal vaccination and otitis media in Australian Aboriginal infants: comparison of two birth cohorts before and after introduction of vaccination. BMC Pediatr, 9, 2009, 14.
11. [11] O'Brien, K.L., David, A.B., Chandran, A., Moulton, L.H., Reid, R., Weatherholtz, R., et al. Randomized, controlled trial efficacy of pneumococcal conjugate vaccine against otitis media among Navajo and White Mountain Apache infants. Pediatr Infect Dis J 27 (2008), 71–73.
12. [12] Taylor, S., Marchisio, P., Vergison, A., Harriague, J., Hausdorff, W.P., Haggard, M., Impact of pneumococcal conjugate vaccination on otitis media: a systematic review. Clin Infect Dis 54 (2012), 1765–1773.
13. [13] Meichtry, J., Born, R., Kuffer, M., Zwahlen, M., Albrich, W.C., Brugger, S.D., et al. Serotype epidemiology of invasive pneumococcal disease in Swiss adults: a nationwide population-based study. Vaccine 8:32 (2014), 5185–5191.
14. [14] Hauser, C., Kronenberg, A., Allemann, A., Muhlemann, K., Hilty, M., Serotype/serogroup-specific antibiotic non-susceptibility of invasive and non-invasive Streptococcus pneumoniae, Switzerland, 2004 to 2014. Eurosurveillance 26:21 (2016), 12–21.
15. [15] Muhlemann, K., Matter, H.C., Tauber, M.G., Bodmer, T., Nationwide surveillance of nasopharyngeal Streptococcus pneumoniae isolates from children with respiratory infection, Switzerland, 1998–1999. J Infect Dis 15:187 (2003), 589–596.
16. [16] Hethcote, H.W., An age-structured model for pertussis transmission. Math Biosci 15:145 (1997), 89–136.
17. [17] Shah, R.K., Roberson, D.W., Jones, D.T., Epiglottitis in the Hemophilus influenzae type B vaccine era: changing trends. Laryngoscope 114 (2004), 557–560.
18. [18] Lau, W.C., Murray, M., El-Turki, A., Saxena, S., Ladhani, S., Long, P., et al. Impact of pneumococcal conjugate vaccines on childhood otitis media in the United Kingdom. Vaccine 22:33 (2015), 5072–5079.
19. [19] Cohen, R., Varon, E., Doit, C., Schlemmer, C., Romain, O., Thollot, F., et al. A 13-year survey of pneumococcal nasopharyngeal carriage in children with acute otitis media following PCV7 and PCV13 implementation. Vaccine 22:33 (2015), 5118–5126.
20. [20] van der Linden, M., Imohl, M., Busse, A., Rose, M., Adam, D., Bacterial spectrum of spontaneously ruptured otitis media in the era of pneumococcal conjugate vaccination in Germany. Eur J Pediatr 174 (2015), 355–364.
21. [21] van Hoek, A.J., Sheppard, C.L., Andrews, N.J., Waight, P.A., Slack, M.P., Harrison, T.G., et al. Pneumococcal carriage in children and adults two years after introduction of the thirteen valent pneumococcal conjugate vaccine in England. Vaccine 23:32 (2014), 4349–4355.
22. [22] Blanchard-Rohner, G., Gervaix, A., Impact of vaccination on acute otitis media. Rev Med Suisse 17:12 (2016), 350–353.
23. [23] Nunes, S., Felix, S., Valente, C., Simoes, A.S., Tavares, D.A., Almeida, S.T., et al. The impact of private use of PCV7 in 2009 and 2010 on serotypes and antimicrobial resistance of Streptococcus pneumoniae carried by young children in Portugal: comparison with data obtained since 1996 generating a 15-year study prior to PCV13 introduction. Vaccine 29:34 (2016), 1648–1656.
24. [24] Parra, E.L., De La Hoz, F., Diaz, P.L., Sanabria, O., Realpe, M.E., Moreno, J., Changes in Streptococcus pneumoniae serotype distribution in invasive disease and nasopharyngeal carriage after the heptavalent pneumococcal conjugate vaccine introduction in Bogota, Colombia. Vaccine 20:31 (2013), 4033–4038.
25. [25] Ben-Shimol, S., Givon-Lavi, N., Greenberg, D., Dagan, R., Pneumococcal nasopharyngeal carriage in children ∗5 years of age visiting the pediatric emergency room in relation to PCV7 and PCV13 introduction in southern Israel. Hum Vaccin Immunother 12 (2016), 268–276.
26. [26] Leibovitz, E., Serebro, M., Givon-Lavi, N., Greenberg, D., Broides, A., Leiberman, A., et al. Epidemiologic and microbiologic characteristics of culture-positive spontaneous otorrhea in children with acute otitis media. Pediatr Infect Dis J 28 (2009), 381–384.
27. [27] Stamboulidis, K., Chatzaki, D., Poulakou, G., Ioannidou, S., Lebessi, E., Katsarolis, I., et al. The impact of the heptavalent pneumococcal conjugate vaccine on the epidemiology of acute otitis media complicated by otorrhea. Pediatr Infect Dis J 30 (2011), 551–555.
28. [28] Dagan, R., Pelton, S., Bakaletz, L., Cohen, R., Prevention of early episodes of otitis media by pneumococcal vaccines might reduce progression to complex disease. Lancet Infect Dis 16 (2016), 480–492.
29. [29] Palmu, A.A., Herva, E., Savolainen, H., Karma, P., Makela, P.H., Kilpi, T.M., Association of clinical signs and symptoms with bacterial findings in acute otitis media. Clin Infect Dis 15:38 (2004), 234–242.
30. [30] Andrews, N.J., Waight, P.A., Burbidge, P., Pearce, E., Roalfe, L., Zancolli, M., et al. Serotype-specific effectiveness and correlates of protection for the 13-valent pneumococcal conjugate vaccine: a postlicensure indirect cohort study. Lancet Infect Dis 14 (2014), 839–846.
31. [31] Croucher, N.J., Mitchell, A.M., Gould, K.A., Inverarity, D., Barquist, L., Feltwell, T., et al. Dominant role of nucleotide substitution in the diversification of serotype 3 pneumococci over decades and during a single infection. PLoS Genet, 9, 2013, e1003868.
32. [32] Yeh, S.H., Gurtman, A., Hurley, D.C., Block, S.L., Schwartz, R.H., Patterson, S., et al. Immunogenicity and safety of 13-valent pneumococcal conjugate vaccine in infants and toddlers. Pediatrics 126 (2010), e493–e505.
33. [33] Brugger, S.D., Frey, P., Aebi, S., Hinds, J., Muhlemann, K., Multiple colonization with S. pneumoniae before and after introduction of the seven-valent conjugated pneumococcal polysaccharide vaccine. PLoS One, 5, 2010, e11638.
34. [34] Brugger, S.D., Hathaway, L.J., Muhlemann, K., Detection of Streptococcus pneumoniae strain cocolonization in the nasopharynx. J Clin Microbiol 47 (2009), 1750–1756.
35. [35] Valente, C., Hinds, J., Gould, K.A., Pinto, F.R., de Lencastre, H., Sa-Leao, R., Impact of the 13-valent pneumococcal conjugate vaccine on Streptococcus pneumoniae multiple serotype carriage. Vaccine 25:34 (2016), 4072–4078.
36. [36] Valente, C., Hinds, J., Pinto, F., Brugger, S.D., Gould, K., Muhlemann, K., et al. Decrease in pneumococcal co-colonization following vaccination with the seven-valent pneumococcal conjugate vaccine. PLoS One, 7, 2012, e30235.
37. [37] Hilty, M., Qi, W., Brugger, S.D., Frei, L., Agyeman, P., Frey, P.M., et al. Nasopharyngeal microbiota in infants with acute otitis media. J Infect Dis 205 (2012), 1048–1055.